| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/17/1992 | CA2103901A1 Insecticidally effective peptides isolatable from diguetia spider venom |
| 09/16/1992 | WO1992016845A1 Receptor-based screening methods for amylin agonists and antagonists |
| 09/16/1992 | WO1992016645A1 PROTEIN PRODUCTION FROM IMMORTAL CELLS GROWN $i(IN VIVO) |
| 09/16/1992 | WO1992016623A2 Receptors for bombesin-like peptides |
| 09/16/1992 | EP0504043A1 Cosmetic composition containing phospholipid transfer proteins |
| 09/16/1992 | EP0503950A2 Method of purifying recombinant hepatitis B virus surface proteins from recombinant cells |
| 09/16/1992 | EP0503648A1 CD2-Binding domain of lymphocyte function associated antigen 3 |
| 09/16/1992 | EP0503646A1 Monoclonal antibodies recognizing lymphocyte function associated antigen-3 |
| 09/16/1992 | EP0503484A2 Monoclonal antibodies as antidotes |
| 09/16/1992 | EP0503297A1 GLIA activating factor and its production |
| 09/16/1992 | EP0503252A2 Recombinant proteins having the immunoreactivity of Hepatitis B virus e antigens (HBeAg), method for their production and their application in immunoassays and as vaccines |
| 09/16/1992 | EP0503050A1 Hybrid growth factors |
| 09/16/1992 | EP0503045A1 Cloning cartridges and expression vectors in gram-negative bacteria |
| 09/16/1992 | EP0502962A1 Hirudine polyalkylene glycol conjugates. |
| 09/16/1992 | EP0502928A1 METHODS OF DETECTING COLLAGEN DEGRADATION -i(IN VIVO). |
| 09/16/1992 | EP0502927A1 Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
| 09/16/1992 | EP0502892A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 09/16/1992 | EP0502886A1 Storage device. |
| 09/16/1992 | EP0267224B1 Process for the production of a polypeptide |
| 09/16/1992 | EP0245520B1 Monoclonal antibody against glutathione s-transferase and its use in the diagnosis of cancer |
| 09/16/1992 | CA2105306A1 Receptors for bombesin-like peptides |
| 09/16/1992 | CA2104787A1 Protein production from immortal cells grown in vivo |
| 09/16/1992 | CA2082929A1 Receptor-based screening methods for amylin agonists and antagonists |
| 09/16/1992 | CA2062460A1 A method of stabilizing recombinant hepatitis b virus surface proteins from recombinant host cells |
| 09/15/1992 | WO1992016644A1 Means for in-vitro diagnosis of constituents of cytoplasmic granules and biological applications |
| 09/15/1992 | WO1992016643A1 Recombinant hybrid porin epitopes |
| 09/15/1992 | WO1992016627A1 Recombinant anticoccidial vaccine |
| 09/15/1992 | WO1992016228A1 TGF-β1/β2: A NOVEL CHIMERIC TRANSFORMING GROWTH FACTOR-BETA |
| 09/15/1992 | US5147788 Baculovirus vectors and methods of use |
| 09/15/1992 | US5147640 Strains of bacillus thuringiensis insecticidal compositions containing the same |
| 09/15/1992 | US5147639 Type-c rotavirus cultures and uses therefor |
| 09/15/1992 | CA2106193A1 Means for in vitro diagnosis of constituents of cytoplasmic granules and biological applications |
| 09/15/1992 | CA2106093A1 Recombinant anticoccidial vaccine |
| 09/15/1992 | CA2105877A1 Tgf-.beta.1/.beta.2: novel chimeric transforming growth factor-beta |
| 09/15/1992 | CA1307486C Hybridoma production |
| 09/15/1992 | CA1307484C Method for culturing recombinant cells |
| 09/15/1992 | CA1307483C Process for producing protein a and composition thereof |
| 09/15/1992 | CA1307482C Vectors and expression sequences for production of polypeptides |
| 09/15/1992 | CA1307479C Diagnostic methods and systems for quantifying apo ai |
| 09/15/1992 | CA1307478C Methods and compositions for the identification of metastatic human tumors |
| 09/13/1992 | WO1992016646A1 Anti-idiotype antibodies to human melanoma-associated proteoglycan antigen |
| 09/13/1992 | WO1992016622A1 Cd2-binding domain of lymphocyte function associated antigen 3 |
| 09/13/1992 | WO1992016562A1 Humanised antibodies having modified allotypic determinants |
| 09/13/1992 | CA2105980A1 Humanised antibodies having modified allotypic determinants |
| 09/13/1992 | CA2105477A1 Anti-idiotype antibodies to human melanoma-associated proteoglycan antigen |
| 09/12/1992 | WO1992015698A1 Murine monoclonal antibodies recognizing polymorphic determinants of hla |
| 09/12/1992 | CA2105969A1 Murine monoclonal antibodies recognizing polymorphic determinants of hla |
| 09/10/1992 | CA2062410A1 Recombinant proteins with the immunoreactivity of hepatitis b virus e antigen (hbeag), a process for the preparation thereof and the use thereof in immunoassays and vaccines |
| 09/09/1992 | EP0502812A1 Recombinant antibodies specific for a growth factor receptor |
| 09/09/1992 | EP0502718A1 Natural and synthetic proteins with inhibitory activity towards pathogenic microorganisms |
| 09/09/1992 | EP0502637A2 Vector |
| 09/09/1992 | EP0502553A2 Peptide fragment from human villin and antibody thereto |
| 09/09/1992 | EP0502496A2 Novel heparitinase, process for producing the same and bacteria producing the same |
| 09/09/1992 | EP0502474A2 Curculin B and DNA encoding same, and process for production thereof |
| 09/09/1992 | EP0502416A1 Stimulation of growth with anti-idiotypic antibodies raised against an antibody to a growth potentiating polypeptide |
| 09/09/1992 | EP0502160A1 Aids therapy and vaccine |
| 09/09/1992 | EP0502124A1 Peptides and antibodies that inhibit integrin-ligand binding |
| 09/09/1992 | EP0502105A1 Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens |
| 09/09/1992 | EP0502099A1 Chimeric proteins |
| 09/09/1992 | EP0494931A4 Monoclonal antibodies to segments of hiv-1 reverse transcriptase |
| 09/09/1992 | EP0473716A4 Dominant negative members of the steroid/thyroid superfamily of receptors |
| 09/09/1992 | CN1064313A Realignment protein of human digestive enzyme and process for their preparation |
| 09/09/1992 | CN1064217A Pneumococcal polysaccharide conjugate vaccine |
| 09/08/1992 | US5145773 Contact with monoclonal antibodies to form antigen-antibody complex |
| 09/08/1992 | US5145676 Method and agents for promoting wound healing |
| 09/08/1992 | CA1307218C Onco-fetal specific monoclonal antibodies methods of preparation and use |
| 09/08/1992 | CA1307217C Monoclonal antibodies specific for eikenella corrodens |
| 09/07/1992 | WO1992015683A1 Humanized and chimeric monoclonal antibodies |
| 09/07/1992 | WO1992015681A1 HUMAN GALANIN, cDNA CLONES ENCODING HUMAN GALANIN AND A METHOD OF PRODUCING HUMAN GALANIN |
| 09/07/1992 | CA2105572A1 Human galanin, cdna clones encoding human galanin and a method of producing human galanin |
| 09/05/1992 | CA2062174A1 Curculin b and dna encoding same, and process for production thereof |
| 09/05/1992 | CA2061862A1 Natural and synthetic proteins with inhibitory activity towards pathogenic microorganisms |
| 09/03/1992 | WO1992014833A1 Cell-free and whole cell ice nucleators and process for their production |
| 09/03/1992 | WO1992014830A1 Enzymatic reverse hydrolysis of hydrophilic substrates - preparation of amphiphilic compounds |
| 09/03/1992 | WO1992014823A1 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 09/03/1992 | WO1992014822A1 A high sulfur seed protein gene and method for increasing the sulfur amino acid content of plants |
| 09/03/1992 | WO1992014757A1 Endothelial cell-monocyte adhesion molecule |
| 09/03/1992 | WO1992014750A1 Recombinant thrombin receptor and related pharmaceuticals |
| 09/03/1992 | WO1992014749A1 Thyroid-derived chondrocyte-stimulating factor |
| 09/03/1992 | CA2104394A1 Recombinant thrombin receptor and related pharmaceuticals |
| 09/02/1992 | WO1992015695A1 Process for the c-terminal modification of peptides having a c_terminal penultimate proline residue |
| 09/02/1992 | WO1992015679A1 Improved epitode displaying phage |
| 09/02/1992 | EP0501914A1 Improved yeast vectors |
| 09/02/1992 | EP0501821A2 Anti-thrombin polypeptides |
| 09/02/1992 | EP0501779A1 Antibodies reactive with human cytosolic phospholipase A2 |
| 09/02/1992 | EP0501692A2 Fermentation processes for the production of peptides by a host |
| 09/02/1992 | EP0501445A1 Pharmaceutical composition comprising interleukin-2 |
| 09/02/1992 | EP0501233A1 Hybridomas and monoclonal antibodies that inhibit anti-CD3-stimulated T cell proliferation |
| 09/02/1992 | EP0501215A2 Fusion proteins with monoclonal antibody, Linker and beta Glucuronidase for prodrug activation; preparation and use thereof |
| 09/02/1992 | EP0500826A1 Apo ai polypeptides, antibodies, and immunoassays |
| 09/02/1992 | EP0500785A1 A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
| 09/02/1992 | EP0500773A1 Non-glycosylated fgf-4 and compositions containing the same |
| 09/02/1992 | EP0500734A1 Protein complexes having factor viii:c activity and production thereof |
| 09/02/1992 | EP0500652A1 Enhancement of cell growth by expression of a cloned hemoglobin gene |
| 09/02/1992 | EP0500626A1 Promoter, expression vector and polypeptide synthesis |
| 09/02/1992 | EP0493418A4 Method of producing fusion proteins |
| 09/02/1992 | CA2105303A1 Display phage |
| 09/02/1992 | CA2101074A1 Process for the c-terminal modification of peptides having a c-terminal penultimate proline residue |
| 09/02/1992 | CA2061738A1 Antibodies reactive with human cytosolic phospholipase a2 |
| 09/01/1992 | US5143846 Protease deficient bacterial hosts |